Dose Escalation Study of SH U04722 in Solid Tumors
NCT00375453
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Tumors
Interventions
DRUG:
SH U04722
Sponsor
Bayer